Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice
Active surveillance (AS) is standard for early-stage prostate cancer, though intensive monitoring continues due to concerns about reclassification to Grade Group (GG) ⩾ 2. We hypothesized that simple and inexpensive clinical parameters could identify patients with indolent disease for whom less intensive monitoring is safe.

